Diabetes with chronic complications, hypertension with chronic complications, obesity show age-dependent effects
Americans Will Have Access to Yellow Fever Vaccines
To meet the yellow fever vaccination needs, the Stamaril vaccine will continue to be available in the USA into mid-2021.
As announced by Sanofi Pasteur in France on December 23, 2020, the U.S. FDA has agreed to authorize the distribution of Stamaril through an Expanded Access Program (EAP) during the YF-VAX vaccine shortage. This EAP is forecast to be effective through mid-2021.
No Evidence Found of Placental Infection, Vertical Transmission of SARS-CoV-2
Mother-to-neonate transfer of anti-SARS-CoV-2 antibodies significantly lower than anti-influenza hemagglutinin A antibody transfer
Majority Do Not Support COVID-19 Vaccine Mandates for Adults
Employer mandates deemed more acceptable than state mandates
Public Health Videos Cut COVID-19 Knowledge Gap for Minorities
Messages from race/ethnic-concordant physicians increase information-seeking incidence for Black participants
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 21 to 23, 2020. This …
First COVID-19 Cases Reported in Antarctica
Until now, Antarctica had been the only continent that was free of the virus
COVID-19 Mortality Rates Dropped Over First Months of Pandemic
Hospital-level risk-standardized event rates worse in association with higher county-level COVID-19 case rates
Universal Cancer Vaccine Launches Phase 2 Clinical Trial
A Phase II randomized clinical trial will evaluate a proprietary universal cancer vaccine, UV1, in patients with recurrent or metastatic head and neck cancer who will be treated with standard of care therapy pembrolizumab.
UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.
The trial will be conducted at ten sites across Germany and led by principal investigator Prof. Mascha Binder, M.D., Medical Director, and Head of the Immunological Tumor Group at University Medicine Halle, Germany.
Care Rationing Being Considered by California Hospitals
California has more than twice as many hospitalized COVID-19 patients as it did at its previous peak in July